early T cell progenitor acute lymphoblastic leukemia
early T cell progenitor acute lymphoblastic leukemia
Explore linked clinical trials. Standard reference: MONDO:01002912 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations | Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, digestive system disorder, early T cell progenitor acute lymphoblastic leukemia, hematologic disorder, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, pyloric stenosis, stomach disorder | Recruiting | Phase 2 | 2025-06-10 | NCT07012447 | |
| Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL | early T cell progenitor acute lymphoblastic leukemia | Recruiting | Phase 3 | 2025-02-17 | NCT06361329 |